Literature DB >> 427326

Pharmacological properties of acetylcholine-induced excitation of subthalamic nucleus neurones.

J Feger, C Hammond, B Rouzaire-Dubois.   

Abstract

1. In 15 rats anaesthetized with ketamine, microiontophoretically applied acetylcholine (ACh) excited all 58 cells studied in the subthalamic nucleus (STN). 2. The ACh-evoked excitation was slow in onset and outlasted the ACh application. There was no sign of desensitization when the ACh application was prolonged or repeated. The excitation was prolonged by a concomitant application of physostigmine. 3. Acetyl-beta-methyl choline and oxotremorine were effective cholinomimetics. Nicotine had no effect. 4. The ACh excitation was antagonized by stropine and scopolamine but not by mecamylamine. 5. It was condluded that STN ACh receptors are muscarinic in character. 6. Since large microiontophoretic applications of Mg2+ did not suppress ACh-evoked excitation, it is suggested that ACh acts postsynaptically. 7. The excitatory response of STN cells to striatal or pallidal stimulation was unaffected by atropine administered either microiontophoretically to single cells or intravenously (3 mg/kg) to the whole animal.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 427326      PMCID: PMC1668650          DOI: 10.1111/j.1476-5381.1979.tb07859.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  12 in total

1.  THE PHARMACOLOGY OF THE SYNAPTIC AND ACETYLCHOLINE-INDUCED EXCITATION OF VENTROBASAL THALAMIC NEURONES.

Authors:  P ANDERSEN; D R CURTIS
Journal:  Acta Physiol Scand       Date:  1964 May-Jun

2.  The action of procaine and atropine on spinal neurones.

Authors:  D R CURTIS; J W PHILLIS
Journal:  J Physiol       Date:  1960-08       Impact factor: 5.182

3.  Pharmacological properties of acetylcholine-sensitive cells in the cerebral cortex.

Authors:  K Krnjević; J W Phillis
Journal:  J Physiol       Date:  1963-05       Impact factor: 5.182

4.  Cholinesterasic striatopallidal and striatonigral efferents in the cat and the monkey.

Authors:  A Olivier; A Parent; H Simard; L J Poirier
Journal:  Brain Res       Date:  1970-03-03       Impact factor: 3.252

5.  Efferent projections of the subthalamic nucleus: an autoradiographic study in monkey and cat.

Authors:  H J Nauta; M Cole
Journal:  J Comp Neurol       Date:  1978-07-01       Impact factor: 3.215

6.  Topographic atlas of catecholamine and acetylcholinesterase-containing neurons in the rat brain. I. Forebrain (telencephalon, diencephalon).

Authors:  D M Jacobowitz; M Palkovits
Journal:  J Comp Neurol       Date:  1974-09-01       Impact factor: 3.215

7.  Efferent fibers of the subthalamic nucleus in the monkey. A comparison of the efferent projections of the subthalamic nucleus, substantia nigra and globus pallidus.

Authors:  M B Carpenter; N L Strominger
Journal:  Am J Anat       Date:  1967-07

8.  The organization of pallidosubthalamic fibers in the monkey.

Authors:  M B Carpenter; R A Fraser; J E Shriver
Journal:  Brain Res       Date:  1968-12       Impact factor: 3.252

9.  Pharmacological characterization of the excitatory cholinergic receptors of rat central neurones.

Authors:  H McLennan; T P Hicks
Journal:  Neuropharmacology       Date:  1978-06       Impact factor: 5.250

10.  The ascending cholinergic reticular system: neocortical, olfactory and subcortical projections.

Authors:  C C Shute; P R Lewis
Journal:  Brain       Date:  1967-09       Impact factor: 13.501

View more
  2 in total

1.  Roles of the M1 muscarinic acetylcholine receptor subtype in the regulation of basal ganglia function and implications for the treatment of Parkinson's disease.

Authors:  Zixiu Xiang; Analisa D Thompson; Carrie K Jones; Craig W Lindsley; P Jeffrey Conn
Journal:  J Pharmacol Exp Ther       Date:  2011-12-01       Impact factor: 4.030

2.  Cholinergic and non-cholinergic mesopontine tegmental neurons projecting to the subthalamic nucleus in the rat.

Authors:  Takako Kita; Hitoshi Kita
Journal:  Eur J Neurosci       Date:  2010-12-31       Impact factor: 3.386

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.